Report #2845341

Received Jun 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: KY
Recovered: Unknown
Vaccinated: May 27, 2025
Onset: May 27, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HIBV	HIB (PEDVAXHIB)	MERCK & CO. INC.	UNK	X007544	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE reported; PEDVAX HIB was administered to 1 consumer following a temperature excursion. No additional AE reported.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On 27-May-2025, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAX HIB) (1 dosage form, lot # X007544, expiration date: 20-Nov-2025; strength, route of administration, dose number in series and anatomical site not provided) for prophylaxis. The vaccine was administered following a temperature excursion: 18.8C for 9 hours and 20 minutes (Product storage error). There was no previous temperature excursion. No additional adverse event reported.